Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 10 | 10 | 10 | 10 | 10 |
| Accounts receivable | -57 | 2 | 0 | 116 | -22 |
| Accounts payable and accrued liabilities | 443 | -177 | -273 | -158 | 350 |
| Other Working Capital | 1,915 | -126 | -103 | -278 | 434 |
| Other Operating Activity | -4,260 | -842 | -952 | -1,596 | -2,779 |
| Operating Cash Flow | $-1,950 | $-1,133 | $-1,317 | $-1,906 | $-2,008 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | 0 | -3 | N/A |
| Investing Cash Flow | $0 | $0 | $0 | $-3 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 6,450 | 2,259 | 0 | 0 |
| Other Financing Activity | 39 | -1,070 | 84 | 88 | -22 |
| Financing Cash Flow | $39 | $5,380 | $2,343 | $88 | $-22 |
| Exchange Rate Effect | -147 | -46 | -81 | 228 | -136 |
| Beginning Cash Position | 7,656 | 3,456 | 2,512 | 4,106 | 6,273 |
| End Cash Position | 5,599 | 7,656 | 3,456 | 2,512 | 4,106 |
| Net Cash Flow | $-1,910 | $4,246 | $1,025 | $-1,822 | $-2,030 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,950 | -1,133 | -1,317 | -1,906 | -2,008 |
| Capital Expenditure | N/A | N/A | N/A | -3 | N/A |
| Free Cash Flow | -1,950 | -1,133 | -1,317 | -1,910 | -2,008 |